INTERINDIVIDUAL VARIATIONS IN DRUG DISPOSITION - CLINICAL IMPLICATIONS AND METHODS OF INVESTIGATION

被引:137
作者
BREIMER, DD
机构
关键词
D O I
10.2165/00003088-198308050-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:371 / 377
页数:7
相关论文
共 34 条
[1]   INDIVIDUAL-DIFFERENCES IN DISPOSITION OF DRUGS METABOLIZED IN BODY [J].
ALVAN, G .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :155-175
[2]   INTRAINDIVIDUAL VARIATION IN DRUG DISPOSITION [J].
ALVARES, AP ;
KAPPAS, A ;
EISEMAN, JL ;
ANDERSON, KE ;
PANTUCK, CB ;
PANTUCK, EJ ;
HSIAO, KC ;
GARLAND, WA ;
CONNEY, AH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :407-419
[3]   FAMILY STUDY OF ANTIPYRINE CLEARANCE [J].
BLAIN, PG ;
MUCKLOW, JC ;
WOOD, P ;
ROBERTS, DF ;
RAWLINS, MD .
BRITISH MEDICAL JOURNAL, 1982, 284 (6310) :150-152
[4]   COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN [J].
BOOBIS, AR ;
BRODIE, MJ ;
KAHN, GC ;
TOVERUD, EL ;
BLAIR, IA ;
MURRAY, S ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :771-777
[5]  
BREIMER DD, 1983, PHARMACOKINETICS MOD
[6]  
BREIMER DD, 1980, BETTER SAFETY DRUGS
[7]  
CONNEY AH, 1980, MICROSOMESDRUG OXIDA, P1103
[8]   3-HYDROXYMETHYL ANTIPYRINE EXCRETION IN URINE AFTER AN ORAL DOSE OF ANTIPYRINE - A RECONSIDERATION OF PREVIOUSLY PUBLISHED AND SYNTHESIS OF A PURE REFERENCE SUBSTANCE [J].
DANHOF, M ;
TEUNISSEN, MWE ;
BREIMER, DD .
PHARMACOLOGY, 1982, 24 (03) :181-184
[9]   INFLUENCE OF THE GENETICALLY CONTROLLED DEFICIENCY IN DEBRISOQUINE HYDROXYLATION ON ANTIPYRINE METABOLITE FORMATION [J].
DANHOF, M ;
IDLE, JR ;
TEUNISSEN, MWE ;
SLOAN, TP ;
BREIMER, DD ;
SMITH, RL .
PHARMACOLOGY, 1981, 22 (06) :349-358
[10]   ASSAY OF ANTIPYRINE AND ITS PRIMARY METABOLITES IN PLASMA, SALIVA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND SOME PRELIMINARY-RESULTS IN MAN [J].
DANHOF, M ;
GROOTVANDERVIS, ED ;
BREIMER, DD .
PHARMACOLOGY, 1979, 18 (04) :210-223